| NCT ID | NCT05908279 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-05-01 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Previous work has shown that a statistical property of gait characterised by long-range autocorrelation functions is altered in Parkinson disease (PD). On the other hand it has been suggested that the same property is linked to the ability in healthy humans to co-regulate the amplitude and cadence of strides towards maintaining a constant speed. Here the investigators want to better understand why it is altered in PD by measuring the transitions between gait instructed by a metronome, and gait without metronome. The experimental conditions will allow the comparisons between these transitions across PD and healthy groups of volunteers, and assess differences based on statistical and computational modelling. The link with potential freezing episodes will also be studied to assess whether the statistical determinants of gait control in this population can be used as a proxy or predictor of the occurence of freezing episodes.
Eligibility Criteria
Inclusion Criteria: * Patients and volunteers able to walk for 20mins and without other neurological disorders. Exclusion Criteria: * Patients or volunteers unable to walk for 20mins and with other neurological disorders.
Contact & Investigator
Frederic Crevecoeur
STUDY DIRECTOR
Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT05908279 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05908279 currently recruiting?
Yes, NCT05908279 is actively recruiting participants. Contact the research team at andre.mouraux@uclouvain.be for enrollment information.
Where is the NCT05908279 trial being conducted?
This trial is being conducted at Louvain-la-Neuve, Belgium.
Who is sponsoring the NCT05908279 clinical trial?
NCT05908279 is sponsored by Université Catholique de Louvain. The principal investigator is Frederic Crevecoeur at Université Catholique de Louvain. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.